Welcome to our dedicated page for Traccom news (Ticker: TRCC), a resource for investors and traders seeking the latest updates and insights on Traccom stock.
The TRCC news page on Stock Titan aggregates announcements and updates related to Traccom Inc., a Pink Open Market technology issuer focused on Causal AI, knowledge management, and AI-based data solutions through its operating subsidiary Vulcain Inc. Here, readers can review company press releases that outline how Traccom’s business has evolved from hardware products to AI platforms and joint ventures.
Recent news highlights include Traccom’s acquisition of Vulcain Inc., which made Vulcain its wholly owned and main operating subsidiary, and positioned the company in the Technology, AI sector. Coverage also includes details of Vulcain’s Causal AI platform, which is used for harmonizing, testing, and validating data to extract and commercialize knowledge, as well as its work with consumer‑packaged goods brands and plans to expand into insurance, healthcare, financial services, and other industries.
Another key topic in the TRCC news feed is the Memorandum of Understanding between Vulcain and Vocodia Holdings Inc. to form a joint venture around Narrative AI. Articles explain how this initiative combines Causal AI with voice AI to support real time event monitoring, Response Management©, and decision-making across use cases such as emergency management, logistics, healthcare, and financial risk monitoring.
Historical releases on the page also describe Traccom’s earlier focus on the Traccom MedicalPro™ remote patient monitoring device and the Traccom Basic™ Tracker for luggage and general tracking, along with marketing and supply agreements tied to those products. Investors and observers can use this news archive to follow how Traccom’s strategy, partnerships, and product emphasis have developed over time.
Traccom Inc. (OTCMKTS: TRCC) and Vocodia Holdings Inc. (OTCMKTS: VHAI) have signed a Memorandum of Understanding to form a joint venture introducing Narrative AI, a solution combining causal analysis with advanced voice AI technology. The platform integrates Vulcain's Causal AI to monitor real-time critical events and triggers immediate actionable responses when event breaches are predicted.
The system goes beyond traditional text-based alerts by enabling intelligent dialogue about impending events and recommending mitigation actions. Current applications include emergency management, logistics, healthcare, and financial risk monitoring. The partnership has established a preliminary pipeline across multiple industries and is targeting aggressive revenue growth for 2025.
Key features include real-time causal event monitoring, Response Management© with natural-sounding voice AI, cross-industry applications, and scalable integration capabilities.
Traccom Inc. (TRCC) has acquired all capital stock of Vulcain Inc. on November 13, 2024. The transaction involved issuing 117,813,680 shares of Traccom common stock, representing 95% of fully diluted shares. Vulcain, now Traccom's main operating subsidiary, added three board members including Greg Duffell as CEO, President and CFO. Vulcain specializes in Causal AI solutions, serving leading US CPG brands with plans to expand into Insurance, Healthcare, and Financial Services. The company's platform uses causal machine learning algorithms and domain experts to provide predictive outcomes for business risks and opportunities.
Traccom (OTC Pink: TRCC) has entered into a global marketing agreement with R & R Marketing Services, Inc. to promote the Traccom Basic Tracker™. This partnership leverages R & R's expertise in social media and Amazon sales to enhance market reach. The Traccom Basic Tracker aids travelers by providing real-time luggage location updates. Additionally, Traccom has developed a Remote Patient Monitoring device, the Traccom MedicalPro™, offering various health monitoring capabilities. Both products are now ready for full production.
Traccom (OTC Pink: TRCC) has signed a Supply Agreement Letter of Intent with Diabetic Direct, Inc. to supply its Traccom MedicalPro™ remote patient monitoring device. This partnership targets the substantial market of 37 million U.S. diabetics, offering a crucial opportunity for Traccom's growth. The MedicalPro™ device enables health monitoring at home, with real-time data uploaded securely for healthcare providers. Both the MedicalPro™ and the Traccom Basic™ Tracker are now ready for full production, enhancing Traccom's position in the healthcare technology sector.
Traccom (OTC Pink: TRCC) announced a price reduction for the remaining 336,228 shares in its Reg A+ Tier 2 offering, decreasing the price from $2.85 to $1.82 per share, aiming for total proceeds of approximately $601,419. The funds will be allocated primarily for inventory production and corporate operating expenses, subject to SEC approval of the post-effective amendment filed on June 17, 2022. The company is gearing up for full production of its two breakthrough products in healthcare and tracking technology.